series-c-plus
Stage
1
Investors
About
Tourmaline Bio develops early-stage cancer diagnostic tests based on circulating tumor DNA to enable early detection and risk assessment of cancer.
Explore Tourmaline Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.